Mysoline Articles
Sinclair IS Pharma divests Mysoline to Lab SERB for £11 million
15 November 2011
Strong earnings growth for Ireland's Elan on healthy US sales
11 February 2002
Elan and Vernalis antimigraine drug wins US approval
12 November 2001
Elan net income leaps 89% in 1st qtr
24 April 2001
Elan full-year 2000 sales top $1.50 billion
29 January 2001
Liposome and Segix boost Elan revenues
21 July 2000
Elan Corp gains approval of Zonegran in USA for epilepsy
29 March 2000
Draxis Health markets Mysoline in Canada
2 March 2000
Hefty increase in 3rd qtr revenues at Elan
26 October 1999
Revenues Rise 63% At Ireland's Elan Corp In Third Quarter
27 October 1998
Elan's 2nd Qtr Revenues Leap 82%
30 July 1998
Elan Posts Record Growth In 1st Quarter 1998
27 April 1998
Elan's Zonisamide Nears US Approval
25 March 1998
Elan To Acquire Wyeth's Mysoline
19 February 1998
Encouraging Results With Tiagabine
9 January 1995
POLFA AND HOECHST DEAL
21 December 1992
Showing 1-21 of 21 articles
- 1
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
